SCHEMBL6597910

SCHEMBL6597910

COc1ccc(OC(F)(F)F)cc1C(=O)N(C)CC(CCN1CCCN(c2nc3ccccc3n2Cc2ccco2)CC1)c1ccc(F)cc1

nearest known ligand 0.35

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
MAPT P10636 3/20 0.35
TACR1 P25103 3/20 0.35
ALDH1A1 P00352 2/20 0.35
MEN1 O00255 1/20 0.35
GAA P10253 1/20 0.35
HTT P42858 1/20 0.35
KMT2A Q03164 1/20 0.35
HRH1 P35367 5/20 0.34
CYP2D6 P10635 4/20 0.34
CHRM1 P11229 2/20 0.34
LMNA P02545 1/20 0.34
TSHR P16473 2/20 0.33
KCNH2 Q12809 2/20 0.33
POLB P06746 1/20 0.33
TACR2 P21452 2/20 0.33
HSD17B10 Q99714 1/20 0.33
TACR3 P29371 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6595000 0.91 HRH1 (0.37) TACR1HRH1CYP2D6CHRM1KCNH2
SCHEMBL6594143 0.90 LMNA (0.36) MAPTTACR1ALDH1A1MEN1KMT2A
SCHEMBL6596451 0.89 ALDH1A1 (0.36) MAPTTACR1ALDH1A1LMNA
SCHEMBL6596461 0.89 CHRM1 (0.39) MAPTALDH1A1HRH1CHRM1LMNA
SCHEMBL6596700 0.89 MEN1 (0.36) MAPTTACR1ALDH1A1MEN1KMT2A
SCHEMBL6594420 0.88 LMNA (0.35) MAPTTACR1ALDH1A1MEN1KMT2A
SCHEMBL6594416 0.88 LMNA (0.35) MAPTTACR1ALDH1A1MEN1KMT2A
SCHEMBL6599290 0.87 MAPT (0.34) MAPTALDH1A1MEN1GAAHTT
SCHEMBL6596301 0.87 HRH1 (0.42) MAPTALDH1A1MEN1GAAHTT
SCHEMBL6596243 0.86 MAPT (0.34) MAPTALDH1A1MEN1GAAHTT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0888338-B1 NOVEL SUBSTITUTED N-METHYL-N-(4-(4-(1H-BENZIMIDAZOL-2-YL) 1,4]DIAZEPAN-1-YL)-2-(ARYL)BUTYL)BENZAMIDES USEFUL FOR THE TREATMENT OF ALLERGIC DISEASES AVENTIS PHARMA INC (US) 2004-11-17 EP disclosed
EP-0888338-A1 NOVEL SUBSTITUTED N-METHYL-N-(4-(4-(1H-BENZIMIDAZOL-2-YL) 1,4]DIAZEPAN-1-YL)-2-(ARYL)BUTYL)BENZAMIDES USEFUL FOR THE TREATMENT OF ALLERGIC DISEASES HOECHST MARION ROUSSEL, INC. (US) 1999-01-07 EP disclosed
WO-1997030991-A1 NOVEL SUBSTITUTED N-METHYL-N-(4-(4-(1H-BENZIMIDAZOL-2-YL)[1,4]DIAZEPAN-1-YL)-2-(ARYL)BUTYL)BENZAMIDES USEFUL FOR THE TREATMENT OF ALLERGIC DISEASES HOECHST MARION ROUSSEL, INC. (US) 1997-08-28 WO disclosed